View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Uncategorized
June 11, 2020

AstraZeneca and Gilead Sciences merger would be the biggest in the pharma history

By Victoria Smith

AstraZeneca, the UK’s largest drugmaker, has allegedly contacted American biopharmaceutical company Gilead Sciences regarding a potential merger deal in an informal approach and aimed at testing its US rivals interest in the deal.

Previously, Gilead has focused on obtaining smaller pharmaceutical companies, formerly shifting away from more extensive merger deals with Big Pharma companies. Read more here.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology